Form 4 for CRSP CRISPR Therapeutics AG
Accepted 2022-12-06 00:00:00 ET · period of report 2022-12-03 · accession 0001209191-22-060093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-06 | 2022-12-03 | CRSP | Kulkarni Samarth | CEO, Dir | M - OptEx | — | +40.0K | 330.3K | +14% | — |
| D | 2022-12-06 | 2022-12-05 | CRSP | Kulkarni Samarth | CEO, Dir | F - Tax | $52.26 | -19.4K | 310.9K | -6% | -$1.01M |
| D | 2022-12-06 | 2022-12-03 | CRSP | Kulkarni Samarth | CEO, Dir | M - OptEx | — | +40.0K | 0 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-12-03 | M | A | 40,000 | — | 330,279 | D | — | — | (F1) The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. (F2) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. |
| 2 | Common | Common Shares | 2022-12-05 | F | D | 19,401 | $52.26 | 310,878 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-12-03 | M | A | 40,000 | — | 0 | D | — · — to — | 40,000 Common Shares | (F2) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. (F1) The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. |